A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata - Chwalisz, K; Larsen, L; Mattia-Goldberg, C; Edmonds, A; Elger, W; Winkel, C A (Fertil Steril, 2007)